These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29404340)

  • 1. Assays of D-Amino Acid Oxidase Activity.
    Rosini E; Caldinelli L; Piubelli L
    Front Mol Biosci; 2017; 4():102. PubMed ID: 29404340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research.
    Kuo CY; Lin CH; Lane HY
    CNS Drugs; 2022 Nov; 36(11):1143-1153. PubMed ID: 36194364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties and applications of microbial D-amino acid oxidases: current state and perspectives.
    Pollegioni L; Molla G; Sacchi S; Rosini E; Verga R; Pilone MS
    Appl Microbiol Biotechnol; 2008 Feb; 78(1):1-16. PubMed ID: 18084756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human D-Amino Acid Oxidase: Structure, Function, and Regulation.
    Pollegioni L; Sacchi S; Murtas G
    Front Mol Biosci; 2018; 5():107. PubMed ID: 30547037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies.
    Sacchi S; Cappelletti P; Murtas G
    Front Mol Biosci; 2018; 5():55. PubMed ID: 29946548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human d-amino acid oxidase: The inactive G183R variant.
    Murtas G; Caldinelli L; Cappelletti P; Sacchi S; Pollegioni L
    Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(7):822-830. PubMed ID: 29274788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors.
    Smith SM; Uslaner JM; Hutson PH
    Open Med Chem J; 2010 May; 4():3-9. PubMed ID: 20648222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
    Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
    FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
    Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
    Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase.
    Molla G
    Front Mol Biosci; 2017; 4():80. PubMed ID: 29250527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.
    Sacchi S; Rosini E; Pollegioni L; Molla G
    Curr Pharm Des; 2013; 19(14):2499-511. PubMed ID: 23116391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coumarin derivatives as inhibitors of d-amino acid oxidase and monoamine oxidase.
    Bester E; Petzer A; Petzer JP
    Bioorg Chem; 2022 Jun; 123():105791. PubMed ID: 35413582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assays of D-amino acid oxidases.
    Tedeschi G; Pollegioni L; Negri A
    Methods Mol Biol; 2012; 794():381-95. PubMed ID: 21956578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New biotech applications from evolved D-amino acid oxidases.
    Pollegioni L; Molla G
    Trends Biotechnol; 2011 Jun; 29(6):276-83. PubMed ID: 21397351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel thermostable D-amino acid oxidase of the thermophilic fungus Rasamsonia emersonii strain YA.
    Shimekake Y; Furuichi T; Abe K; Kera Y; Takahashi S
    Sci Rep; 2019 Aug; 9(1):11948. PubMed ID: 31420577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical Properties of Human D-Amino Acid Oxidase.
    Murtas G; Sacchi S; Valentino M; Pollegioni L
    Front Mol Biosci; 2017; 4():88. PubMed ID: 29326945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-amino acid oxidase: its potential in the production of 7-aminocephalosporanic acid.
    Mujawar SK
    Hindustan Antibiot Bull; 1999; 41(1-4):1-14. PubMed ID: 12024974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulating D-amino acid oxidase (DAAO) substrate specificity through facilitated solvent access.
    Subramanian K; Góra A; Spruijt R; Mitusińska K; Suarez-Diez M; Martins Dos Santos V; Schaap PJ
    PLoS One; 2018; 13(6):e0198990. PubMed ID: 29906280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.
    Sershen H; Hashim A; Dunlop DS; Suckow RF; Cooper TB; Javitt DC
    Neurochem Res; 2016 Feb; 41(1-2):398-408. PubMed ID: 26857796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.
    Szilágyi B; Ferenczy GG; Keserű GM
    Expert Opin Drug Discov; 2018 Oct; 13(10):973-982. PubMed ID: 30220232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.